USA - Washington

A bill adding restrictions on manufacturing and sales of hemp cannabinoid products was generally well received, but many speakers disagreed with the allowable THC limits.

Hearings on WSLCB THC legislation, cannabis waste, advertising, low dose products, patient arrest protections, local override, home grow, and the fate of concentrates were all scheduled.

WSLCB officials were peppered with questions as they discussed their regulatory practices around youth access, social equity, hemp, and agency reorganization with lawmakers.

Senators heard supportive testimony on a bill addressing retail theft and four new bills were prepared for introduction, including two targeting concentrated cannabis products.

Interstate commerce was moved to the Senate floor, the policy committee in the senate planned to take action, two bills were set for introduction, and next week’s schedule was announced.

Unanimously supportive testimony on a bill to remove the cannabis excise tax for medical patients registered with the state called attention to problems around taxing medicine.

Republican representatives were poised to introduce a bill to radically revise the excise tax structure by THC concentration after the public weighed in against taxing patients.

Board members expressed their willingness to support multiple bills for medical cannabis patients and spoke at length about their approach to interacting with the state legislature.

The out-of-state ownership bill was heard, two seasoned bills were set for introduction, and medical cannabis patients would make their case for excise tax exemption in 2023.

Legislation to permit out-of-state ownership and suspend inactive producers received mostly supportive testimony, with opposition centered on equity implications from the change.